![](/img/cover-not-exists.png)
Efficacy and Safety of Secukinumab in Japanese Patients with Active Ankylosing Spondylitis: 24-week Results from an Open-label Phase 3 Study (MEASURE 2-J)
Kishimoto, Mitsumasa, Taniguchi, Atsuo, Fujishige, Ayako, Kaneko, Shuhei, Haemmerle, Sibylle, Porter, Brian O., Kobayashi, ShigetoLanguage:
english
Journal:
Modern Rheumatology
DOI:
10.1080/14397595.2018.1538004
Date:
October, 2018
File:
PDF, 874 KB
english, 2018